Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.

Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ.

Breast Cancer Res Treat. 2011 Nov;130(2):635-44. doi: 10.1007/s10549-011-1646-4.

PMID:
21717106
2.

Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.

Chu QD, Burton G, Glass J, Smith MH, Li BD.

J Am Coll Surg. 2010 May;210(5):585-92, 592-4. doi: 10.1016/j.jamcollsurg.2010.01.025.

PMID:
20421009
3.

African-American and low-socioeconomic status patients have a worse prognosis for invasive ductal and lobular breast carcinoma: do screening criteria need to change?

Yang R, Cheung MC, Franceschi D, Hurley J, Huang Y, Livingstone AS, Koniaris LG.

J Am Coll Surg. 2009 May;208(5):853-68; discussion 869-70. doi: 10.1016/j.jamcollsurg.2008.10.038.

PMID:
19476849
4.

Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.

Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Esserman LJ.

Ann Surg Oncol. 2012 Nov;19(12):3979-86. doi: 10.1245/s10434-012-2415-2.

PMID:
22622474
5.

Race and ethnicity and breast cancer outcomes in an underinsured population.

Komenaka IK, Martinez ME, Pennington RE Jr, Hsu CH, Clare SE, Thompson PA, Murphy C, Zork NM, Goulet RJ Jr.

J Natl Cancer Inst. 2010 Aug 4;102(15):1178-87. doi: 10.1093/jnci/djq215.

6.
7.

Primary tumor size, not race, determines outcomes in women with hormone-responsive breast cancer.

Chagpar AB, Crutcher CR, Cornwell LB, McMasters KM.

Surgery. 2011 Oct;150(4):796-801. doi: 10.1016/j.surg.2011.07.066.

PMID:
22000193
8.

Race is a fundamental prognostic indicator for 2325 northeastern Ohio women with infiltrating breast cancer.

Crowe JP Jr, Patrick RJ, Rybicki LA, Grundfest-Broniatowski S, Kim JA, Lee KB.

Breast J. 2005 Mar-Apr;11(2):124-8.

PMID:
15730458
10.

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK.

J Natl Cancer Inst. 1994 May 4;86(9):705-12.

PMID:
7908990
11.

Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer.

Moran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG.

Cancer. 2008 Nov 1;113(9):2565-74. doi: 10.1002/cncr.23881.

12.

Regional and racial disparities in breast cancer-specific mortality.

Grann V, Troxel AB, Zojwalla N, Hershman D, Glied SA, Jacobson JS.

Soc Sci Med. 2006 Jan;62(2):337-47.

PMID:
16051406
13.

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW.

Breast Cancer Res Treat. 2009 Jan;113(2):357-70. doi: 10.1007/s10549-008-9926-3.

PMID:
18324472
14.
15.
16.

Differences in breast cancer stage, treatment, and survival by race and ethnicity.

Li CI, Malone KE, Daling JR.

Arch Intern Med. 2003 Jan 13;163(1):49-56.

PMID:
12523916
17.

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175.

18.

The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.

Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ.

PLoS One. 2013 Oct 29;8(10):e79114. doi: 10.1371/journal.pone.0079114.

19.

Does utilization of screening mammography explain racial and ethnic differences in breast cancer?

Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, Dignan M, Barlow WE, Beasley CM, Kerlikowske K.

Ann Intern Med. 2006 Apr 18;144(8):541-53.

PMID:
16618951
20.

Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy.

Vicini F, Jones P, Rivers A, Wallace M, Mitchell C, Kestin L, Jaiyesimi I, Dekhne N, Martinez A.

Cancer. 2010 Jul 15;116(14):3485-92. doi: 10.1002/cncr.25088.

Items per page

Supplemental Content

Support Center